The latest quarterly R&D expense is $6.02 Million with a QoQ Growth of -10.74%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $6.02M.
$6.02M
$6.02 Million
Q2 FY2026 · 2026-06-30
-10.74%
vs. $6.74M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $6.02M | -10.74% | +88.09% |
| Q1 FY2026Period end 2026-03-31 | $6.74M | -1.98% | -12.31% |
| Q4 FY2025Period end 2025-12-31 | $6.88M | -1.73% | +27.46% |
| Q3 FY2025Period end 2025-09-30 | $7.00M | +118.75% | -15.53% |
| Q2 FY2025Period end 2025-06-30 | $3.20M | -58.39% | -73.66% |
| Q1 FY2025Period end 2025-03-31 | $7.69M | +42.49% | -47.53% |
| Q4 FY2024Period end 2024-12-31 | $5.40M | -34.87% | -63.82% |
| Q3 FY2024Period end 2024-09-30 | $8.29M | -31.79% | -42.57% |
| Q2 FY2024Period end 2024-06-30 | $12.15M | -17.10% | -10.26% |
| Q1 FY2024Period end 2024-03-31 | $14.65M | -1.77% | +22.28% |
| Q4 FY2023Period end 2023-12-31 | $14.92M | +3.40% | +70.46% |
| Q3 FY2023Period end 2023-09-30 | $14.43M | +6.58% | +71.20% |
| Q2 FY2023Period end 2023-06-30 | $13.54M | +12.96% | +102.12% |
| Q1 FY2023Period end 2023-03-31 | $11.98M | +36.94% | +112.76% |
| Q4 FY2022Period end 2022-12-31 | $8.75M | +3.84% | +50.58% |
| Q3 FY2022Period end 2022-09-30 | $8.43M | +25.83% | +57.68% |
| Q2 FY2022Period end 2022-06-30 | $6.70M | +18.91% | +63.37% |
| Q1 FY2022Period end 2022-03-31 | $5.63M | -3.08% | +241.60% |
| Q4 FY2021Period end 2021-12-31 | $5.81M | +8.74% | N/A |
| Q3 FY2021Period end 2021-09-30 | $5.34M | +30.37% | N/A |
| Q2 FY2021Period end 2021-06-30 | $4.10M | +148.64% | N/A |
| Q1 FY2021Period end 2021-03-31 | $1.65M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
